Accuracy of reporting endocervical component adequacy--a continuous quality improvement project

Area of Science:

• Cytopathology
• Laboratory Quality Improvement
• Gynecologic Oncology Screening

Background:

• Inaccurate reporting of endocervical (EC) component adequacy on Pap smears leads to repeat testing and clinician dissatisfaction.
• EC component reporting accuracy is a critical quality indicator in cytopathology laboratories.

Purpose of the Study:

• To evaluate the impact of a continuous quality improvement (CQI) program on the accuracy of reporting EC component adequacy in Pap smears.
• To determine if targeted interventions can improve the reliability of EC component assessment.

Main Methods:

• A baseline audit of 300 Pap smears (150 adequate EC, 150 inadequate EC) assessed reporting accuracy.
• Implementation of a CQI program including staff education, standardized criteria, and improved marking techniques.
• A post-intervention audit of 300 Pap smears evaluated changes in reporting accuracy.

Main Results:

• Baseline accuracy for adequate EC component reporting was 98%; for absent EC component, it was 71%.
• After CQI implementation, accuracy for adequate EC component remained 98%, while accuracy for absent EC component improved to 90%.
• The improvement in reporting absent EC component adequacy was statistically significant (P = 0.015).

Conclusions:

• A structured CQI program effectively enhanced the accuracy of reporting EC component adequacy on Pap smears.
• Applying quality improvement principles to cytopathology reporting issues can yield significant positive outcomes.
• Improved EC component reporting accuracy minimizes unnecessary repeat smears and enhances clinician confidence.